Loading...

HOSPITAL INITIATED INJECTABLE OPIOID AGONIST THERAPY FOR THE TREATMENT OF SEVERE OPIOID USE DISORDER

BACKGROUND: Across North America, there is an unprecedented opioid overdose epidemic. Approximately 15% of individuals with severe opioid use disorder (OUD) do not benefit from opioid agonist therapy (OAT) such as buprenorphine/naloxone or methadone and are considered treatment refractory. Of those...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Addict Med
Main Authors: Brar, Rupinder, Fairbairn, Nadia, Colizza, Kate, Ryan, Andrea, Nolan, Seonaid
Format: Artigo
Sprog:Inglês
Udgivet: 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927900/
https://ncbi.nlm.nih.gov/pubmed/32769776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ADM.0000000000000713
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!